Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00745381 · ClinicalTrials.gov registry record
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 238
- Enrollment target
NCT00745381: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00745381 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 238 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00745381 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 238 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a neuroendocrine tumor registry. A registry is a collection of information. To create this registry, the investigators would like to get information, blood and tumor samples from people with neuroendocrine tumors. By collecting this information and material, the investigators are hoping to learn more about the genetic causes of neuroendocrine tumors. All of this will help us to better understand neuroendocrine cancer, so the investigators can find better ways to treat and diagnose this disease. DNA will be taken from the blood samples and will be used in future studies. This will be an important resource from which the investigators can study genes that may be related to a higher risk of neuroendocrine tumors. The information collected will include medical information, family history of cancer and your answers to questions about how the cancer affects quality of life.
Interventions
- OTHER questionnaire, Blood specimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2008-08 |
| Est. Completion | 2020-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00745381
The ClinicalTrials.gov registry entry for NCT00745381 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaire, Blood specimens is the first listed.
NCT00745381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00745381 about?
NCT00745381 is a clinical study titled "A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors". The purpose of this study is to establish a neuroendocrine tumor registry. A registry is a collection of information. To create this registry, the investigators would like to get information, blood and tumor samples from people with neuroendocrine tumors. By collecting this information and material,...
What is the current status of trial NCT00745381?
This trial is currently completed. The enrollment target is 238 participants. The study started on 2008-08. Estimated completion is 2020-07-30.
What interventions are being tested in trial NCT00745381?
The interventions under investigation include: questionnaire, Blood specimens (OTHER).
Who is sponsoring clinical trial NCT00745381?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.